As a BioMimetic Therapeutics (BMTI)
shareholder, I have long regarded a buy-out as the overwhelmingly
logical end game for the company. While I would have initially preferred
to see one of the ortho giants like Johnson & Johnson (JNJ), Stryker (SYK), or Zimmer (ZMH) make the bid, the combination with Wright Medical Group (WMGI) could ultimately prove a lot more powerful for both companies than the Street currently seems to believe.
Please follow this link for more:
BioMimetic Looks Like Serious Augmentation For Wright Medical
No comments:
Post a Comment